Dihydrobiopterin reductase
Dihydrobiopterin reductase is an enzyme that catalyzes the reversible formation of tetrahydrobiopterin from dihydrobiopterine using NADPH. A deficiency of this enzyme can result in malignant hyperphenylalaninemia.[1]
Dihydrobiopterin is a compound produced in the synthesis of dopamine, norepinephrine and epinephrine through production of the intermediate 3,4-dihydroxy phenylalanine, also known as dopa. Phenylalanine is converted into dopa using tetrahydrobiopterin releasing dihydrobiopterin and water, which is then converted back into tetrahydrobiopterin using the NADPH-dependent enzyme dihydrobiopterin reductase. This enzyme is sometimes defective in patients with phenylketonuria, and is treated in the same fashion, with tyrosine supplements and a controlled diet which is lacking in phenylalanine.[2]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />